Skip to content

NightOwl Pulse Oximeter Calibration Study

NightOwl Pulse Oximeter Calibration Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03774199
Acronym
NPOCS
Enrollment
30
Registered
2018-12-12
Start date
2018-12-14
Completion date
2020-04-14
Last updated
2019-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulse Oximeter Calibration

Brief summary

Calibration of a software module that computes SpO2 based on photoplethysmography (PPG) traces acquired by a reflectance-based pulse oximeter which can be placed on the index finger or the forehead. The study is designed in accordance with Medical electrical equipment - Part 2-61: Particular requirements for basic safety and essential performance of pulse oximeter equipment (ISO 80601- 2-61:2011)

Interventions

DEVICENightOwl

The NightOwl is a finger and/or forehead mounted device with, among other functions, the capability to acquire double-wavelength PPG, from which SpO2 can be derived

Sponsors

Ectosense NV
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
13 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* healthy subjects (ASA 1 and ASA 2) upon signing the informed consent. (ASA : american society of anesthesiologist's health score)

Exclusion criteria

* smokers or individuals exposed to high levels of carbon monoxide that result in elevated carboxyhaemoglobin levels. * individuals subject to conditions that result in elevated levels of methaemoglobin. * individuals with arterial cannulation or hypoxia at FiO2 = 0,21

Design outcomes

Primary

MeasureTime frameDescription
A_rms determinationWithin 3 months after subject recruitment, the calibration and ARMS determination should have been performed.After calibration of the NightOwl SpO2 software module, the A\_rms metric will be computed. This metric constitutes the performance metric proposed by ISO 80601-2-61:2011 Annex CC: Determination of accuracy. This metric captures the bias and precision of the computed SpO2 values compared to the benchmark.

Countries

Belgium

Contacts

Primary ContactFrederik Roger Massie, ir
frederik.massie@ectosense.com474942710

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026